Jaime E Hale
Overview
Explore the profile of Jaime E Hale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Green D, Lahiri T, Raraigh K, Ruiz F, Spano J, Antos N, et al.
Pediatrics
. 2024 Apr;
153(5).
PMID: 38577740
A multidisciplinary committee developed evidence-based guidelines for the management of cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen-positive, inconclusive diagnosis (CRMS/CFSPID). A total of 24 patient, intervention, comparison, and...
2.
Kharrazi M, Sacramento C, Marie Comeau A, Hale J, Caggana M, Kay D, et al.
Int J Neonatal Screen
. 2022 Nov;
8(4).
PMID: 36412584
Testing immunoreactive trypsinogen (IRT) is the first step in cystic fibrosis (CF) newborn screening. While high IRT is associated with CF, some cases are missed. This survey aimed to find...
3.
Ma K, Hale J, Grad Y, Alter G, Luzuriaga K, Eaton R, et al.
Clin Infect Dis
. 2022 Feb;
75(1):e105-e113.
PMID: 35213690
Background: Estimating the cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for setting public health policies. We leveraged deidentified Massachusetts newborn screening specimens as an accessible,...
4.
Kumar B, Barton S, Kordowska J, Eaton R, Counihan A, Hale J, et al.
Int J Neonatal Screen
. 2021 Aug;
7(3).
PMID: 34449530
Promising treatments for spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, prompted calls for inclusion in newborn screening (NBS). In January 2018, the New England Newborn Screening...
5.
Hale J, Darras B, Swoboda K, Estrella E, Chen J, Abbott M, et al.
Int J Neonatal Screen
. 2021 Jun;
7(2).
PMID: 34071063
Massachusetts began newborn screening (NBS) for Spinal Muscular Atrophy (SMA) following the availability of new treatment options. The New England Newborn Screening Program developed, validated, and implemented a screening algorithm...
6.
Hale J, Platt C, Bonilla F, Hay B, Sullivan J, Johnston A, et al.
J Allergy Clin Immunol Pract
. 2021 Feb;
9(5):2060-2067.e2.
PMID: 33607339
Background: Massachusetts began newborn screening (NBS) for severe combined immunodeficiency (SCID) using measurement of T-cell receptor excision circles (TRECs) from dried blood spots. Objective: We describe developments and outcomes from...
7.
Purswani P, Meehan C, Kuehn H, Chang Y, Dasso J, Meyer A, et al.
Front Pediatr
. 2019 Apr;
7:55.
PMID: 31024866
In the era of newborn screening (NBS) for severe combined immunodeficiency (SCID) and the possibility of gene therapy (GT), it is important to link SCID phenotype to the underlying genetic...
8.
Goda V, Malik A, Kalmar T, Maroti Z, Patel B, Ujhazi B, et al.
J Allergy Clin Immunol Pract
. 2018 Feb;
6(5):1769-1771.e2.
PMID: 29410113
No abstract available.
9.
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States
Kwan A, Abraham R, Currier R, Brower A, Andruszewski K, Abbott J, et al.
JAMA
. 2014 Aug;
312(7):729-38.
PMID: 25138334
Importance: Newborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended...
10.
Sahai I, Eaton R, Hale J, Mulcahy E, Marie Comeau A
Genet Med
. 2010 Dec;
12(12 Suppl):S220-7.
PMID: 21150368
To fulfill the purpose of newborn screening, comprehensive newborn screening programs must ensure that infants and children with newborn screening conditions are not only diagnosed but also they maintain engagement...